Salute e Benessere

Zealand Pharma announces positive topline results from the Phase 1b 16-week…

Company announcement – No. 32 / 2024 Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintideBody weight reductions of up to a mean of 8.6% with high dose petrelintide after 16 weekly doses (1.7% with placebo)Petrelintide was judged to be safe and well tolerated at all dose levelsResults provide robust support of the potential of petrelintide as an effective alternative to...
Nasdaq GlobeNewswire
20/06/2024

Custom T-shirt Printing Market Size to Hit $12,059.5 million by 2031: Coherent…

Market Dynamics: Market Dynamics: The custom t-shirt printing market is driven by increasing popularity of customized fashion among millennial population across the globe. Custom printed t-shirts allow customers to design their own t-shirts with unique graphics, logos, and slogans according to their preferences. This has increased the demand for custom printing over the recent past. Moreover, availability of wide range of fabrics, styles, designs, and printing technologies has further...
PR Newswire
20/06/2024

Abzena and Argonaut Partner to Offer Accelerated End-to-End Drug Development…

The partnership removes the white space in drug development for biopharma drug companies by utilizing a single development and manufacturing team to seamlessly transition from early discovery services (ranging from antibody engineering, developability, formulation development, cell line development, process and analytical development) through clinical and commercial manufacturing of drug substance and drug product. This tight integration of activities facilitates more informed and rapid…
PR Newswire
20/06/2024

Rapafusyn Pharmaceuticals Secures $28 Million Series A to Advance Its…

Rapafusyn's RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging or previously undruggable disease targets Financing led by 3E Bioventures Capital and Proxima Ventures Ltd. with participation from Lapam Capital Founded by Professor Jun O. Liu of Johns Hopkins University School of Medicine, a pioneer in the molecular glue field BALTIMORE, June20, 2024(GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals,...
Nasdaq GlobeNewswire
20/06/2024

Minimally Invasive Surgical Instruments Market Surges to USD 49.9 Billion by…

Browse in-depth TOC on "Minimally Invasive Surgical Instruments Market" Browse in-depth TOC on "Minimally Invasive Surgical Instruments Market" 450 - Tables 54 - Figures 428 - Pages TheJune 2024edition of the minimally invasive surgical instruments market report introduces significant enhancements and updates to provide a comprehensive view of the market: These enhancements in theJune 2024edition aim to deliver deeper insights and a more comprehensive...
PR Newswire
20/06/2024

Ventilators Market to be Worth $13.23 Billion by 2031 - Exclusive Report by…

A ventilator is a medical device designed to deliver oxygen into a person's body through a tube inserted into the windpipe, typically through the mouth or nose. Before entering the body, the air passes through a humidifier and filter to ensure it is clean and comfortable to breathe. Ventilators are equipped with adjustable settings for controlling the breathing rate and the volume of air delivered to the patient. A ventilator is a medical device designed to deliver oxygen into a person's body...
PR Newswire
20/06/2024

LELO partners up with Sexy Living

"We are excited to bring true innovation to even more consumers, especially in these challenging times. For us, this means playing a crucial part in opening up the adult products category worldwide. Just like we design our products for the future, we also act for the future - thus, we need to contribute to the well-being of people, and providing pleasure plays a huge part in that. Our existing and future customers in Canada deserve nothing less" says Louise Wong, Senior Business…
PR Newswire
20/06/2024

Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing…

Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in AfricaParis, June 20, 2024.Sanofi and Biovac, a Cape Town, South Africa-based biopharmaceutical company, announce today their local manufacturing partnership to produce inactivated polio vaccines (IPV) in Africa. This agreement is designed to enable regional manufacturing of polio vaccines to serve the potential needs of over 40 African countries. This partnership with Sanofi makes Biovac the first African producer...
Nasdaq GlobeNewswire
20/06/2024

Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX…

SAN DIEGO, and CALGARY, AB, June 20, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, announced the dosing of the first patient in the new GOBLET study cohort evaluating pelareorep and modified FOLFIRINOX (mFOLFIRINOX) with or without atezolizumab (Tecentriq®) in newly diagnosed metastatic pancreatic ductal adenocarcinoma (PDAC) patients. The co-primary endpoints of the cohort are objective…
PR Newswire
20/06/2024

Tilray Medical Launches Broken Coast Medical Cannabis Brand in Australia

Broken Coast EU-GMP Certified Medical Cannabis Whole Flower Products Are Now Available through a Doctor's Prescription in Australia NEW YORK and SYDNEY, June20, 2024(GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, thereby transforming healthcare…
Nasdaq GlobeNewswire
20/06/2024

Roborock Secures Spot in Kantar BrandZ Top 50 Chinese Global Brand Builders for…

BrandZ Award: A Mark of Excellence BrandZ Award: A Mark of Excellence Kantar BrandZ, a globally recognized authority on brand equity, leverages the expansive consumer insights from its Kantar Profiles network. In partnership with Google, the eighth annual Chinese Global Brand Builders Report employs a stringent research methodology, integrating Kantar's extensive database with Google's detailed consumer surveys and search analytics to evaluate over 400 Chinese brands, ultimately...
PR Newswire
20/06/2024

ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of…

With a significant track record of success in the radiopharmaceutical industry, Dr. Cavey will help accelerate ITM's pipeline and business growth Garching / Munich, Germany, June 20, 2024 –ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company today announced the appointment of Dr. Andrew Cavey, as its Chief Executive Officer effective September 1, 2024. ITM's current CEO, Steffen Schuster, will step up to the company's Supervisory Board...
Nasdaq GlobeNewswire
20/06/2024

Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary…

CM313 is a humanized monoclonal antibody targeting CD38 and the first domestically-developed anti-CD38 antibody with IND approval by the NMPA in China. Previous phase I/II studies have demonstrated the favorable safety profile and encouraging efficacy of CM313 in patients with RRMM and primary ITP. In addition, the potential use of CM313 in SLE is currently under clinical development. CM313 is a humanized monoclonal antibody targeting CD38 and the first domestically-developed anti-CD38…
PR Newswire
20/06/2024

iOnctura announces EUR80 million Series B financing to progress pipeline through…

Lead asset roginolisib is the first allosteric modulator of PI3Kδ, with a unique chemical structure and binding mode. It is being developed for indications burdened by immune mediated resistance and a high expression of PI3Kδ in cancer cells and tumor-infiltrating immune cells. Roginolisib has potential to become the first successful, clinically meaningful therapy to target the critical PI3Kδ cancer pathway. It has demonstrated an unprecedented and first-in-class clinical profile in solid and…
PR Newswire
20/06/2024

OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform…

OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disordersat the FOCIS Annual Meeting, San Francisco (June 18 – 21)NANTES, France, June 20, 2024 – 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), presented a poster on preclinical data on its mRNA (messenger RiboNucleic Acid) therapeutic platform for the treatment of inflammatory and autoimmune disorders at the Federation of...
Nasdaq GlobeNewswire
20/06/2024

Basilea partners oncology drug candidate lisavanbulin with Glioblastoma…

Allschwil, Switzerland, June 20, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an asset purchase agreement with the Glioblastoma Foundation Inc., for Basilea's oncology drug candidate lisavanbulin (BAL101553), which has been developed as a potential therapy for glioblastoma, the most common type of primary brain...
Nasdaq GlobeNewswire
20/06/2024

Roche launches new highly-sensitive test to more easily diagnose patients who…

The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity to assess the full spectrum of B-cell lymphoma subtypes. 1,2 The test helps differentiate a B-cell cancer from a normal, reactive immune response, providing diagnostic certainty for healthcare providers and their patients. B-cell lymphoma accounts for approximately 85 percent of non-Hodgkin lymphoma (NHL) cases, which is the tenth...
Nasdaq GlobeNewswire
20/06/2024

Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development…

Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines is expanding its pharmaceutical development capabilities.Behind SynQube GmbH are the two pioneers of cannabis medicine and founders of THC Pharm GmbH, Christian Steup and Holger Rönitz, with more than 25 years of experience with cannabinoids and psychotropic substances.Together, Avextra and SynQube share a wealth of experience and are ideally positioned to pursue joint drug...
Nasdaq GlobeNewswire
20/06/2024

Prediabetes Market is Projected to Boost at a Moderate Growth Rate by 2034…

Key Takeaways from the Prediabetes Market Report Key Takeaways from the Prediabetes Market Report Discover which therapies are expected to grab the major prediabetes market share @Prediabetes Market Report Prediabetes Overview Prediabetes is a condition characterized by blood sugar levels that are higher than normal but not yet high enough to be diagnosed as type 2 diabetes. It serves as a critical warning sign and a window of opportunity for individuals to take steps to...
PR Newswire
19/06/2024

Bioretec reports successful clinical outcomes from U.S. controlled launch of…

Further enquiries Further enquiries Alan Donze, CEO, tel. +358 40 663 5011 Johanna Salko, CFO, tel. +358 40 754 8172 Bioretec in brief Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of biodegradable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and...
PR Newswire
19/06/2024

From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data

Updating the audience for its flagship novel immunotherapy, pelareorep, Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) presented two abstracts demonstrating further potential for the intravenously delivered immunotherapeutic agent in pancreatic cancer and its immunotherapeutic mechanism of action across multiple cancer indications. Updating the audience for its flagship novel immunotherapy, pelareorep,Oncolytics Biotech Inc.(NASDAQ: ONCY) (TSX: ONC)presented two abstracts...
PR Newswire
19/06/2024

OSE Immunotherapeutics Reports on its 2024 General Shareholders' Meeting and the…

OSE Immunotherapeutics Reports on its2024 General Shareholders' Meeting and the Evolution of the Board of Directors Ready to Drive the Strategic Company's GrowthNantes, France – June 19, 2024, 6:15pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)today announced that all the resolutions submitted to a vote at the Combined General Shareholders' Meeting were approved as proposed by OSE Immunotherapeutics' Board of Directors.Shareholders also approved...
Nasdaq GlobeNewswire
19/06/2024

High-Quality Kitchen Appliances and Utensils Converge at the 135th Canton Fair…

Realwin Metal Manufacture Co., Ltd. is presenting its flagship new product, the 7-piece Stainless Steel Cookware Set on the platform. This set is crafted from high-quality stainless steel and composite bottom which not only offers exceptional strength and durability, but also ensures rapid heating and maintains optimal cooking temperature for prolonged periods. As for design, the product incorporates unique contoured edges and precision interior finishing processes to prevent splashing and…
PR Newswire
19/06/2024

Trenbolone Enanthate Industry to hit 91.5 million dollars by 2031: Coherent…

Market Dynamics: Market Dynamics : The global Trenbolone Enanthate market is primarily driven by rising demand for anabolic steroids from bodybuilders and athletes across the globe. Trenbolone enanthate is one of the most commonly used anabolic steroids for bulking and cutting cycles due to its high anabolic and low androgenic properties. It promotes significant gains in muscle mass and strength within short span without much emphasis on water retention. Additionally, increasing awareness...
PR Newswire
19/06/2024
Altri  Comunicati